Patient Name: ____________________________ County: _______________________
BASIC INFORMATION LOG: 12-Dose Isoniazid-Rifapentine Latent TB Infection Treatment Dose and Symptom Monitoring
Patient ID: ____________ Age:________ Sex: M / F Ethnicity: Hispanic / Non-Hispanic
Race: ______ Weight: ________lbs Height: ______ft/inches
Treatment reason: ☐Contact
☐Corrections
☐Homeless
☐Refugee
☐Foreign-born
☐Convertor
Dose: INH ______mg RPT______mg
*Check
symptoms or events reported on the listed date; otherwise, leave blank.
Date:
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
__/__/__
0
Dose:
2
3
4
5
6
7
8
9
10
11
12
1
Baseline
Directly Observed Therapy
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
(DOT) received
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
No adverse reaction
Loss of appetite
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Nausea or vomiting
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Yellow eyes or skin
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Diarrhea
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Rash/hives
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Fever or chills
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Sore muscles or joints
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Numbness or tingling
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Fatigue
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Dizziness/fainting
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Abdominal pain
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
(Other)______________
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
Treatment stopped or held
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
☐
(complete AE report on next page)
Final Disposition: ☐ Completed INH-RPT treatment
☐ Stopped INH-RPT treatment
Date __/__/__
☐ Lost to follow-up
☐ Moved
☐ Other
☐ Adverse event
(fill out next page if treatment stopped for AE)
☐ Pending Completion of Alternate Regimen